Modeling Congenital Hyperinsulinism with ABCC8-Deficient Human Embryonic Stem Cells Generated by CRISPR/Cas9
Abstract Congenital hyperinsulinism (CHI) is a rare genetic disorder characterized by excess insulin secretion, which results in hypoglycemia. Mutation of sulfonylurea receptor 1 (SUR1), encoded by the ABCC8 gene, is the main cause of CHI. Here, we captured the phenotype of excess insulin secretion...
Enregistré dans:
Auteurs principaux: | Dongsheng Guo, Haikun Liu, Aynisahan Ruzi, Ge Gao, Abbas Nasir, Yanli Liu, Fan Yang, Feima Wu, Guosheng Xu, Yin-xiong Li |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/2eef6fa0dafc4b3492d08947d95ff76c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
ABCC6 deficiency promotes dyslipidemia and atherosclerosis
par: Christopher Brampton, et autres
Publié: (2021) -
Health-Related Quality of Life of Children and Adolescents With Congenital Hyperinsulinism – A Scoping Review
par: Kaja Kristensen, et autres
Publié: (2021) -
Mutations in UCP2 in congenital hyperinsulinism reveal a role for regulation of insulin secretion.
par: M Mar González-Barroso, et autres
Publié: (2008) -
Transient congenital hyperinsulinism and hemolytic disease of a newborn despite rhesus D prophylaxis: a case report
par: Sandra Simony Tornoe Riis, et autres
Publié: (2021) -
Whole genome SNP genotyping and exome sequencing reveal novel genetic variants and putative causative genes in congenital hyperinsulinism.
par: Maria Carla Proverbio, et autres
Publié: (2013)